Sign in
8-K

Current Report

Jasper Therapeutics, Inc. Filed Acc 0001213900-22-035178

Shareholder vote results

  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading ea162130-8k_jasperthera.htm…